Últimas noticias sobre Agilysys (NASDAQ:AGYS) Bolsa

Agilysys

Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.

Agilysys Inc

In the latest quarter, 5 analysts provided ratings for Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $114.0, a high estimate of $135.00, and a low estimate of $90.00. A decline of 16.18% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1744228855_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Agilysys by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Brian Schwartz &#x7C;Oppenheimer &#x7C;Lowers &#x7C;Outperform &#x7C; $90.00&#x7C;$135.00 &#x7C; 
&#x7C;Mayank Tandon &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $100.00&#x7C;$125.00 &#x7C; 
&#x7C;George Sutton &#x7C;Craig-Hallum &#x7C;Lowers &#x7C;Buy &#x7C; $120.00&#x7C;$125.00 &#x7C; 
&#x7C;Brian Schwartz &#x7C;Oppenheimer &#x7C;Lowers &#x7C;Outperform &#x7C; $135.00&#x7C;$150.00 &#x7C; 
&#x7C;Mayank Tandon &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $125.00&#x7C;$145.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Agilysys. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Agilysys compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Agilysys's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Agilysys's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AGYS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Agilysys analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Agilysys</h2>
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.
<h3>Agilysys: A Financial Overview</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Agilysys's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 14.85% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.51%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Agilysys's ROE excels beyond industry benchmarks, reaching 1.48%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Agilysys's ROA excels beyond industry benchmarks, reaching 0.86%. This signifies efficient management of assets and strong financial health.
Debt Management: Agilysys's debt-to-equity ratio is below the industry average at 0.24, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

AGYS

Agilysys Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

WIIM

ADEA

AEIS

AEVA

AIOT

ALAB

ALAR

ALGM

AMPG

AMPL

ARLO

ASGN

ASTI

ATOM

BASE

BBAI

BELFA

BELFB

BIGC

BLBX

BLZE

BTCT

BZAI

CAMT

CCCS

CCRD

CEVA

CGNX

CLMB

CMPO

COHU

CRDO

CRNC

CRSR

CSIQ

CSPI

CTSH

CWAN

CXDO

DAKT

DAVA

DCBO

DGII

DIOD

DJCO

DMRC

DOCN

DOMO

EBON

EPAM

ETWO

EVCM

EVLV

EXFY

FARO

FCUV

FLEX

FSLR

GDYN

GRRR

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IDCC

INFA

INFY

INGM

INSG

IONQ

IPGP

ITRI

JAMF

Shares of broader tech companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Oppenheimer analyst Brian Schwartz maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Outperform and lowers the price target from $135 to $90.

News

Price Target

Oppenheimer Maintains Outperform on Agilysys, Lowers Price Target to $90

CALX

CIEN

EXTR

FFIV

HIMX

KEYS

LOGI

MCHP

MKSI

MLGO

MNDY

OSIS

PLXS

PSTG

QBTS

RCAT

SANM

SMCI

SOBR

TRMB

TSSI

TWLO

ZBRA

Shares of companies within the broader tech sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Agilysys's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NYSE">AGYS</a>) short percent of float has fallen 18.13% since its last report. The company recently reported that it has 909 thousand shares sold short, which is 4.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Agilysys Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741276833_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Agilysys has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Agilysys's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Agilysys's peer group average for short interest as a percentage of float is 8.96%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Is Agilysys Gaining or Losing Market Support?

Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $133.2, with a high estimate of $186.00 and a low estimate of $100.00. This current average has decreased by 3.48% from the previous average price target of $138.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1741176014_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Agilysys by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>George Sutton</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Brian Schwartz</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$135.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$125.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Nehal Chokshi</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$186.00</td>
<td>$145.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Agilysys. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Agilysys compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Agilysys's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Agilysys's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AGYS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Agilysys analyst ratings.</a>
<h2>Get to Know Agilysys Better</h2>
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.
<h3>Financial Insights: Agilysys</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Agilysys's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 14.85% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Agilysys's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.51%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Agilysys's ROE excels beyond industry benchmarks, reaching 1.48%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Agilysys's ROA excels beyond industry benchmarks, reaching 0.86%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.24, Agilysys adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Agilysys Stock

Needham analyst Mayank Tandon maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Buy and lowers the price target from $125 to $100.

Needham Maintains Buy on Agilysys, Lowers Price Target to $100

Reported Earlier, Agilysys Powers Hamilton Island's Digital Transformation With 11 Integrated Solutions, Including Versa PMS And Mobile Guest Services

<h3>Gainers</h3>
<ul>
<li>Blackboxstocks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares moved upwards by 101.2% to $3.4 during Wednesday's pre-market session. The company's market cap stands at $12.0 million. </li>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock increased by 23.69% to $0.28. The company's market cap stands at $6.7 million. </li>
<li>Mobilicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOB#NASDAQ">MOB</a>) stock rose 13.6% to $3.09. The company's market cap stands at $19.6 million. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares moved upwards by 10.97% to $1.31. The market value of their outstanding shares is at $48.3 million. </li>
<li>Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) stock rose 10.79% to $191.2. The market value of their outstanding shares is at $534.7 billion. </li>
<li>UTStarcom Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTSI#NASDAQ">UTSI</a>) stock increased by 10.58% to $3.03. The market value of their outstanding shares is at $28.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) shares decreased by 24.1% to $95.51 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion. The company's, Q3 earnings came out yesterday. </li>
<li>VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) stock decreased by 13.34% to $2.6. The market value of their outstanding shares is at $27.2 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) shares declined by 10.72% to $1.75. The company's market cap stands at $23.1 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares declined by 9.64% to $1.97. The market value of their outstanding shares is at $1.1 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares decreased by 7.84% to $2.47. The market value of their outstanding shares is at $3.1 million. </li>
<li>Alpha Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) stock decreased by 7.35% to $15.01. The market value of their outstanding shares is at $247.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMOD

ATGL

FOXO

MOBX

MYSZ

ORCL

UTSI

VRME

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Wednesday.
The Dow traded up 0.27% to 44,146.86 while the NASDAQ rose 1.29% to 20,010.85. The S&amp;P 500 also rose, gaining, 0.70% to 6,091.74.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43123084/top-3-health-care-stocks-that-could-blast-off-this-quarter">Top 3 Health Care Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Information technology shares surged by 2.5% on Wednesday.
In trading on Wednesday, utilities shares fell by 1.5%.
Top Headline
Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.
Adjusted diluted earnings per share were $1.34, in line with the analyst estimates and management consensus of $1.31-$1.37, up from $1.19 a year ago.
Abbott projects full-year 2025 adjusted EPS of $5.05-$5.25 versus a consensus of $5.16, with organic sales growth of 7.5%- 8.5% and an adjusted operating margin of 23.5%- 24.0%. Abbott Laboratories expects first quarter 2025 adjusted EPS of $1.05-$1.09 versus consensus of $1.11.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Blackboxstocks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares shot up 101% to $3.39 after the company announced a $250K securities purchase agreement and is anticipating a potential merger.</li>
<li>Shares of Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>)got a boost, surging 26% to $4.0450 after Needham initiated coverage with a Buy rating and a $9 price target.</li>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) shares were also up, gaining 30% to $0.6396 after the company announced it developed a new class of GLP-1 therapies using its LENS platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) shares dropped 21% to $100.00 after the company reported worse-than-expected third-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Shares of Hepion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) were down 61% to $0.1265 after the company announced a $9 million public offering.</li>
<li>Lisata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) was down, falling 30% to $2.72 after the company announced preliminary cohort data from its Phase 2 Ascend trial.</li>
</ul>
Commodities In commodity news, oil traded down 0.4% to $75.55 while gold traded up 0.4% at $2,770.40.
Silver traded down 0.5% to $31.33 on Wednesday, while copper fell 1% to $4.2985.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 surged 0.39%, Germany's DAX 40 rose 1.01% and France's CAC 40 gained 0.86%. Spain's IBEX 35 Index fell 0.37%, while London's FTSE 100 fell 0.04%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 1.58%, China's Shanghai Composite Index falling 0.89%, Hong Kong's Hang Seng Index falling 1.63% and India's BSE Sensex gaining 0.75%.
Economics
U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43125507/apple-to-183-here-are-10-top-analyst-forecasts-for-wednesday">Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

ABSI

HEPA

LSTA

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Wednesday.
The Dow traded up 0.30% to 44,159.42 while the NASDAQ rose 1.48% to 20,049.15. The S&amp;P 500 also rose, gaining, 0.83% to 6,099.61.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43123084/top-3-health-care-stocks-that-could-blast-off-this-quarter">Top 3 Health Care Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Information technology shares surged by 2% on Wednesday.
In trading on Wednesday, real estate shares fell by 1%.
Top Headline
Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) posted better-than-expected second-quarter financial results.
The company reported second-quarter sales growth of 2% year-on-year to $21.9 billion, beating the analyst consensus estimate of $21.542 billion. Adjusted EPS of $1.88 beat the consensus estimate of $1.86.
P&amp;G maintained its guidance range for FY25 organic sales growth of 3%-5% and all-in sales growth of 2%-4%. P&amp;G maintained its FY25 EPS growth outlook of 10%-12% versus an EPS of $6.02 in FY24.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Blackboxstocks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBX#NASDAQ">BLBX</a>) shares shot up 69% to $2.86 after the company announced a $250K securities purchase agreement and is anticipating a potential merger.</li>
<li>Shares of Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>)got a boost, surging 27% to $4.0950 after Needham initiated coverage with a Buy rating and a $9 price target.</li>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) shares were also up, gaining 49% to $0.7322 after the company announced it developed a new class of GLP-1 therapies using its LENS platform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) shares dropped 20% to $101.25 after the company reported worse-than-expected third-quarter sales results and issued FY25 revenue guidance below estimates.</li>
<li>Shares of Hepion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) were down 59% to $0.13 after the company announced a $9 million public offering.</li>
<li>Lisata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) was down, falling 23% to $3.02 after the company announced preliminary cohort data from its Phase 2 Ascend trial.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $75.49 while gold traded up 0.3% at $2,768.10.
Silver traded down 0.6% to $31.320 on Wednesday, while copper fell 0.9% to $4.3015.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 surged 0.49%, Germany's DAX 40 rose 1.16% and France's CAC 40 gained 0.82%. Spain's IBEX 35 Index fell 0.41%, while London's FTSE 100 fell 0.02%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 1.58%, China's Shanghai Composite Index falling 0.89%, Hong Kong's Hang Seng Index falling 1.63% and India's BSE Sensex gaining 0.75%.
Economics
U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43125507/apple-to-183-here-are-10-top-analyst-forecasts-for-wednesday">Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings

Craig-Hallum analyst George Sutton maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Buy and lowers the price target from $125 to $120.

Craig-Hallum Maintains Buy on Agilysys, Lowers Price Target to $120

Oppenheimer analyst Brian Schwartz maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Outperform and lowers the price target from $150 to $135.

Oppenheimer Maintains Outperform on Agilysys, Lowers Price Target to $135

Agilysys shares are trading lower after the company reported worse-than-expected Q3 sales results and issued FY25 revenue guidance below estimates.

<h3>Gainers</h3>
<ul>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares increased by 16.9% to $1.38 during Wednesday's pre-market session. The company's market cap stands at $50.9 million. </li>
<li>Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) stock increased by 8.15% to $186.65. The market value of their outstanding shares is at $522.0 billion. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares moved upwards by 7.83% to $12.39. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares moved upwards by 7.42% to $2.75. The company's market cap stands at $4.9 million. </li>
<li>Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) stock increased by 7.2% to $108.55. The company's market cap stands at $22.9 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) shares moved upwards by 6.93% to $1.85. The market value of their outstanding shares is at $59.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) stock fell 20.7% to $99.79 during Wednesday's pre-market session. The company's market cap stands at $2.7 billion. The company's, Q3 earnings came out yesterday. </li>
<li>VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) stock declined by 9.0% to $2.73. The market value of their outstanding shares is at $28.6 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock decreased by 8.17% to $1.8. The market value of their outstanding shares is at $23.7 million. </li>
<li>908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) stock decreased by 7.6% to $2.8. The market value of their outstanding shares is at $97.5 million. </li>
<li>Neonode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) shares decreased by 7.26% to $7.8. The market value of their outstanding shares is at $130.9 million. </li>
<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) stock fell 6.86% to $1.63. The market value of their outstanding shares is at $11.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CETX

LEDS

MASS

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

NEON

QUBT

Needham analyst Mayank Tandon maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Buy and lowers the price target from $145 to $125.

Needham Maintains Buy on Agilysys, Lowers Price Target to $125

Guidance

Agilysys Sees FY25 Revenue $273M Vs $281.921M Estimate

Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) just disclosed its Q3 earnings on Tuesday, January 21, 2025 at 04:05 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Agilysys beat estimated earnings by 12.0%, reporting an EPS of $0.38 versus an estimate of $0.34.
Revenue was up $8.99 million from the same period last year.
<h3>Historical Earnings Summary</h3>
The company beat on EPS by $0.04 in the last quarter, resulting in a 8.0% drop share price change the following day.
Here's a look at Agilysys's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.30</td>
<td>0.25</td>
<td>0.28</td>
<td>0.26</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.34</td>
<td>0.30</td>
<td>0.32</td>
<td>0.35</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>67.50M</td>
<td>64.47M</td>
<td>61.95M</td>
<td>60.07M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>68.28M</td>
<td>63.51M</td>
<td>62.22M</td>
<td>60.57M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Agilysys <a href="https://www.benzinga.com/quote/AGYS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Agilysys Q3 Earnings

Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.34 by 11.76 percent. This is a 8.57 percent increase over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $69.60 million which missed the analyst consensus estimate of $73.15 million by 4.85 percent. This is a 14.92 percent increase over sales of $60.57 million the same period last year.

Earnings Beats

Earnings Misses

Agilysys Q3 2025 Adj EPS $0.38 Beats $0.34 Estimate, Sales $69.60M Miss $73.15M Estimate

Press Releases

Agilysys Announces Record Revenue of $69.6M in Third Quarter Fiscal 2025

Hamilton Island Enterprises Selects 11 Agilysys Modern Software Solutions – Including Versa Property Management (PMS) – To Enhance Guest Experiences and Support Operational Efficiencies

Agilysys Expands Sales Leadership, Adds Hospitality Software Veteran Dan Bell in Key New Growth Role

Agilysys Announces Its Book4Time Spa Software Solution Will Receive the 2024 ISPA Innovate Award at the 2025 ISPA Conference March 11-13 2025

Legal

Johnson Fistel, PLLP Continues Investigation into Agilysys, Inc. on Behalf of Shareholders Who Incurred Losses

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agilysys, Inc. - AGYS

Bally's Baton Rouge Hotel Modernizes Guest Experiences With 11 Agilysys Software Solutions

C3.ai

Alkami Technology

Alarm.com Holdings

BlackLine

Bitdeer Technologies Group - Ordinary Shares

Bitdeer Technologies

Cleanspark

Sprinklr

Diginex

DoubleVerify Holdings

EverCommerce

Five9

IREN

Jamf Holding

Karooooo

Ncino

NextNav

Opera Limited - American Depositary Shares

Opera

PagerDuty

D-Wave Quantum

LiveRamp Holdings

Riot Platforms

RingCentral

SEMrush Holdings, Inc. Class A Common Stock

SEMrush Hldgs

Tuya Inc. American Depositary Shares, each representing one Class A Ordinary Share

Tuya

Comments

Agilysys

Noticias

Últimas noticias sobre Agilysys (NASDAQ:AGYS) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL